SCHEMBL6963385

SCHEMBL6963385

CCOC(=O)[C@H](CNC(=O)CNC(=O)C(CCC1CCN(C(=O)O)CC1)CCC1CCN(C(=O)OC(C)(C)C)CC1)NS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 2/20 0.46
MMP13 P45452 7/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
MMP1 P03956 3/20 0.41
MMP3 P08254 3/20 0.41
MMP7 P09237 3/20 0.41
MMP9 P14780 3/20 0.41
MMP8 P22894 3/20 0.41
MMP2 P08253 2/20 0.41
GPR119 Q8TDV5 2/20 0.41
MYC P01106 1/20 0.40
MAX P61244 1/20 0.40
LIMK2 P53671 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
TSHR P16473 1/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6964258 0.94 MMP13 (0.50) MMP13MMP1MMP3MMP7MMP9
SCHEMBL6964185 0.94 GPR119 (0.48) MMP13MMP1MMP3MMP7MMP9
SCHEMBL7951214 0.94 TGFBR1 (0.44) MMP13MMP1MMP3MMP7MMP9
SCHEMBL6962633 0.93 MMP13 (0.49) MMP13MMP1MMP3MMP7MMP9
SCHEMBL6968993 0.93 MMP13 (0.50) MMP13MMP1MMP3MMP7MMP9
SCHEMBL6968735 0.92 ITGB3 (0.45) MMP13MMP1MMP3MMP7MMP9
SCHEMBL6974989 0.91 GPR119 (0.42) MMP13MMP1MMP3MMP7MMP9
SCHEMBL6976930 0.90 TGFBR1 (0.45) MMP13MAPT
SCHEMBL6976329 0.89 F2 (0.44) MMP13SMN1; SMN2GPR119KDM4EALDH1A1
SCHEMBL6976888 0.89 GPR119 (0.41) MMP13MMP1MMP3MMP7MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098878-B1 BISPIPERIDINES AS ANTITHROMBOTIC AGENTS CEPHALON FRANCE (FR) 2003-12-17 EP disclosed
US-6333338-B1 ANTICOAGULANTS, CARDIOVASCULAR DISORDERS LABORATOIRE L. LAFON (FR) 2001-12-25 US disclosed